NCT06325410

Brief Summary

over the past decade colon cancer has emerged as the second most deadly and the third most common type of cancer in the world with increasing incidence in Egypt due to life style and diet change. some research showed relation between colon cancer recurrence and advanced tumor staging. To investigators knowledge, this is the first time to be done in Zagazig University. Data was collected from records in a retrospective cohort study

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
9.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

March 11, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 22, 2024

Completed
Last Updated

March 22, 2024

Status Verified

March 1, 2024

Enrollment Period

9.9 years

First QC Date

March 11, 2024

Last Update Submit

March 15, 2024

Conditions

Keywords

colorectalcancerrecurrenceprognosis

Outcome Measures

Primary Outcomes (20)

  • age

    age of patients was obtained from medical records

    through study completion, an average of 5 years

  • sex

    sex of patients was obtained from medical records

    through study completion, an average of 5 years

  • medical disease

    co-existing medical disease was obtained from medical records

    through study completion, an average of 5 years

  • previous surgery

    previous surgical history was obtained from medical records

    through study completion, an average of 5 years

  • CEA

    value of carcino-embryonic antigen was recorded

    through study completion, an average of 5 years

  • tumor grade

    tumor grade after resection from pathology report recorded

    through study completion, an average of 5 years

  • tumor site

    tumor site recorded from operative findings

    through study completion, an average of 5 years

  • tumor size

    tumor size was measured by length x width in cm from records

    through study completion, an average of 5 years

  • surgical margins of resected tumor

    safety margins were assessed from pathological examination under microscopy and recorded in pathology reports, it can be free surgical margins ( no tumor cells) or positive surgical margins( presence of tumor cells)

    through study completion, an average of 5 years

  • neoadjuvant therapy

    history of neoadjuvant therapy before surgery from records obtained

    through study completion, an average of 5 years

  • adjuvant therapy

    history of adjuvant therapy post operative obtained from records

    through study completion, an average of 5 years

  • diet

    diet and dietary life style from history

    through study completion, an average of 5 years

  • occupation

    occupation of the patient at time of surgery and if it was changed

    through study completion, an average of 5 years

  • family history

    history taking of family history of cancer disease

    through study completion, an average of 5 years

  • type of surgery(laparoscopic or open)

    type of operation was laparoscopic or open surgery obtained from records

    through study completion, an average of 5 years

  • soiling by during surgery

    by history from records if there was soiling of the field by tumor cells

    through study completion, an average of 5 years

  • hand sewen or stappled anastmosis

    if there was bowel re-anastmosis after surgery, it was done using a stappler or hand sewing sutures. this was obtained from operative data in patient records

    through study completion, an average of 5 years

  • post operative complications

    from records; if there were post operative complication like fecal fistula

    through study completion, an average of 5 years

  • site of recurrence

    site of tumor recurrence was detected

    through study completion, an average of 5 years

  • type of resected tumor

    type of tumor was recorded from pathology reports

    through study completion, an average of 5 years

Interventions

resection of bowel segment and re-anastmosis or stoma formation

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patient with newely diagnosed colorectal cancer were followed up after surgery to detect if there was a recurrence prospectively, while patients with recurrent colorectal cancer were studied retrospectively to find out factors influencing the recurrence

You may qualify if:

  • Adult patients with newly diagnosed colorectal cancer
  • Age \> 18 years old
  • recurrent cases of colorectal cancer

You may not qualify if:

  • Pediartric patient less than 18 yr
  • In operable or metastatic cancer colon
  • No other malignancies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zagazig University Hospitals

Zagazig, 44519, Egypt

Location

MeSH Terms

Conditions

Colorectal NeoplasmsNeoplasmsRecurrence

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Reham Zakaria, PhD

    faculty of medicine Zagazig University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 11, 2024

First Posted

March 22, 2024

Study Start

January 1, 2013

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

March 22, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

data will be available on demand by contacting the principle investigator

Locations